Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 2010

View Archived Issues

FV-60135-02 ameliorates retinal vascular damage in diabetic rats

SERM GTx-822 prevents oxidative stress

Promising clinical data disclosed on ATI-7505 in CiC

ALKS-27 improves lung function in COPD patients

Promising phase II data presented on NVA-237 in COPD

Pain Therapeutics discovers new mu opioid receptor agonists

New PKD inhibitor CRT-0066101 inhibits pancreatic cell growth

Boston Scientific begins trial to compare Promus Element and Xience Prime stents

Presidio selects HCV NS5A inhibitor PPI-1301 as clinical candidate

CoDa releases phase II efficacy data on Nexagon in venous leg ulcers

Schering claims new gamma-secretase modulators

Wyeth describes new liver X receptor ligands

Bayer Schering identifies new MEK 1 inhibitors

A study of the interactions between dextromethorphan/quinidine, paroxetine and memantine

Interim phase IIa data analysis on Trigemina's TI-001 in chronic daily headache

Vertex reports on phase III ADVANCE trial in HCV infection

GTx reports phase III data on toremifene in prostate cancer

Enrollment opened in phase III Reolysin trial in head and neck cancers

Cytochroma reports phase I/II data on CTAP-101 in CKD-associated hyperparathyroidism

Stem Cell Therapeutics reports on modified REGENESIS stroke trial

OccuLogix changes corporate name to TearLab

FDA approves Lumizyme for late-onset Pompe's disease

FDA grants priority review to Vivitrol sNDA for opioid dependence

Phase IIb trial of Epicept NP-1 in CPN reaches enrollment target

Advanced BioScience and Hawaii Biotech partner on dengue vaccine development

Nippon Boehringer Ingelheim and Astellas extend telmisartan collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...